Chris Gale - Abstract Heart Podcast Ep.3 - Identification of vulnerable plaques and patients by intracoronary near-infrared spectroscopy and ultrasound (PROSPECT II): a prospective natural history study with Proessor David Erlinge
Paper available here: Identification of vulnerable plaques and patients by intracoronary near-infrared spectroscopy and ultrasound (PROSPECT II): a prospective natural history study with Proessor David Erlinge
About Abstract Heart Podcast
Abstract Heart is an audio programme comprising a series of episodes of short interviews with experts. Episodes provide conversational, but focussed summaries of the most important, latest and interesting articles and research in cardiology. Abstract Heart covers the broad range of cardiology as well as sub-specialist areas to keep listeners informed of what’s happening.
Chris is Professor of Cardiovascular Medicine, Consultant Cardiologist at Leeds General Infirmary, UK. Qualifying in...
Chris is Professor of Cardiovascular Medicine, Consultant Cardiologist at Leeds General Infirmary, UK. Qualifying in medicine at the London Hospital Medical College and obtaining a BSc in Psychology, he worked as a Junior Doctor at the Royal London Hospital. After obtaining MRCP, he completed a MRC funded Ph.D in molecular biology. Speciality training was undertaken principally at the Leeds General Infirmary, where he was a Walport and later a NIHR Academic Clinical Lecturer, then achieving a NIHR Clinician Scientist Award and NIHR Clinical Trials Fellowship. As Consultant Cardiologist at Leeds General Infirmary, he practices clinical cardiology with interests in general cardiology and heart failure. He also practices at The Duchy BMI, Harrogate, UK https://www.bmihealthcare.co.uk/consultants/chris-gale#gdpr-out Chris' research incorporates the efficient use of observational and randomised data to deliver population-based studies of cardiovascular care and outcomes. He holds research awards from the NIHR, BHF and Horizon 2020, and has published >220 articles in peer-reviewed journals. He is a FRCP, FESC and member of the British Cardiovascular Society. He has been a member of the Myocardial Ischaemic National Audit Project Steering Group for over a decade. Chris holds a number of leadership positions including Chair of Data Science Group of the EuroHeart project https://www.escardio.org/Research/euroheart, Chair of the European Society of Cardiology Quality Indicator Committee and member of the NICE Indicator Advisory Committee https://www.nice.org.uk/get-involved/meetings-in-public/indicator-advisory-committee-iac/iac-members. He is Deputy Editor of EHJ Quality of Care and Clinical Outcomes https://academic.oup.com/ehjqcco and Chairs several Data Monitoring Committee for randomised clinical trials. Chris can be followed on Twitter where he regularly tweets about cardiology, his research and life in general! @cpgale3 https://twitter.com/cpgale3
David Erlinge received an MD at Lund University, Sweden 1990 followed by a PhD at the same university. He has been a...
David Erlinge received an MD at Lund University, Sweden 1990 followed by a PhD at the same university. He has been a visiting research fellow at Cornell Univ. Med. Coll., New York, NY. The clinical speciality is invasive cardiology (PCI). In 2006 he received the The Lars Werkö distinguished research fellowship and in 2008 he was appointed Professor in Cardiology at Lund University. The research is focused on acute coronary syndromes, vulnerable plaque, therapeutic hypothermia, cardioprotection and platelet function. He has written >300 original articles.